Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaviscon versus Antagel for postprandial acid reflux and the gastric acid pocket in GERD
NL-OMON25536Recruiting
- Sponsor
- KU Leuven
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of magnesium trisilicate in gastroesophageal reflux disease (GERD) (2 arms), sponsored by KU Leuven. Primary endpoint: Number of acid reflux episodes. Started Jun 2012; status: recruiting.
02
Drugs
magnesium trisilicate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NL-OMON25536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25536.